Your browser doesn't support javascript.
loading
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma.
Midha, Shonali; Hartley-Brown, Monique A; Mo, Clifton C; Hossain, Shahrier; Nadeem, Omar; O'Donnell, Elizabeth K; Bianchi, Giada; Sperling, Adam S; Laubach, Jacob P; Richardson, Paul G.
Affiliation
  • Midha S; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
  • Hartley-Brown MA; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
  • Mo CC; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
  • Hossain S; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
  • Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
  • O'Donnell EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
  • Bianchi G; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
  • Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
  • Laubach JP; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
  • Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.
Expert Opin Drug Saf ; 22(11): 1049-1071, 2023.
Article in En | MEDLINE | ID: mdl-37906232
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Multiple Myeloma Limits: Humans Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Multiple Myeloma Limits: Humans Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom